9
Participants
Start Date
February 18, 2020
Primary Completion Date
February 25, 2025
Study Completion Date
February 25, 2025
Crizotinib
Oral
New York University Medical Center (Site 200), New York
Memorial Sloan Kettering Cancer Center (Site 210), New York
Children's Hospital of Philadelphia (Site 750), Philadelphia
Children's National Medical Center (Site 775), Washington D.C.
Johns Hopkins University (Site 250), Baltimore
Children's HealthCare of Atlanta (Site 950), Atlanta
The University of Alabama at Birmingham (Site 700), Birmingham
Indiana University (Site 400), Indianapolis
Lurie Childrens Hospital of Chicago (Site 350), Chicago
University of Chicago (Site 850), Chicago
Washington University - St. Louis (Site 900), St Louis
Childrens Medical Center - Univ. of Texas SW (Site 917), Dallas
Univ of California @ Los Angeles (Site 325), Los Angeles
Children's Hospital Boston (Site 725), Boston
Cincinnati Children's Hospital Medical Center (Site 800), Cincinnati
Memorial Sloan Kettering Cancer Center
OTHER
Children's Hospital of Philadelphia
OTHER
University of Alabama at Birmingham
OTHER